Gum Tech International Announces Board/Management Changes

Apr 23, 2001, 01:00 ET from Gum Tech International Inc.

    PHOENIX, April 23 /PRNewswire Interactive Press Release/ -- Gum Tech
 International Inc., (Nasdaq:   GUMM) today announced a reorganization of its
 Board of Directors.  Effective immediately, Mr. Edward Faber, a director since
 October 2000, will become Chairman of the Board of Directors.  Mr. Faber, who
 has over 30 years of experience building and managing high-technology growth
 companies, will be taking a more active role in the daily operations of the
 Company.  Mr. William Boone, a director since 1998 and who had previously
 retained the position of Chairman, will become Vice-Chairman of the Board of
 Directors.
     Mr. Kenneth Waters, who has been working with Gum Tech as a consultant
 since April 1998 and has been a director since November 2000, has resigned
 from the Board.  Mr. Waters will continue his business consulting agreement
 with the Company with his primary focus on Gum Tech's strategic options and
 long-term business plans.
     Mr. William Hemelt, Chief Financial Officer of Gum Tech since 1998, has
 accepted the additional position of Executive Vice President, Operations for
 the Company.  The added title reflects the corresponding responsibilities Mr.
 Hemelt has been assigned since the inception of Gel Tech LLC.
 
     Gum Tech International, Inc. is an innovative nutrient and drug delivery
 technology company engaged in the development, manufacture and marketing of
 delivery systems for bioactive compounds.  Gum Tech is the majority owner of
 Gel Tech LLC, which markets Zicam(TM) Cold Remedy, a patented, revolutionary
 homeopathic remedy, and Zicam(TM) Allergy Relief, a homeopathic remedy
 designed to provide relief to allergy sufferers.  In a study published in the
 October 2000 issue of the ENT - Ear, Nose & Throat Journal, Zicam(TM) Cold
 Remedy was shown to reduce the duration of the common cold by an average of
 75% when taken at the onset of symptoms.
 
     For additional information, please contact Lynn Romero, Manager of
 Investor Relations, 602-252-1617, ext. 320, lromero@gum-tech.com.  Gum Tech is
 located at 246 East Watkins Street, Phoenix, Arizona 85004.
 
     Gum Tech Forward-Looking Statement Disclaimer:
     This news release contains forward-looking statements within the
 meaning of the Private Securities Litigation Reform Act of 1995.  These
 forward-looking statements are based on the Company's expectations and are
 subject to a number of risks and uncertainties, many of which cannot be
 predicted or quantified and are beyond the Company's control.  Future events
 and actual results could differ materially from those set forth in,
 contemplated by, or underlying the forward-looking statements.  Factors that
 could cause actual results to differ materially from the Company's
 expectations are described in the Company's reports filed pursuant to the
 Securities Exchange Act of 1934.
 
 

SOURCE Gum Tech International Inc.
    PHOENIX, April 23 /PRNewswire Interactive Press Release/ -- Gum Tech
 International Inc., (Nasdaq:   GUMM) today announced a reorganization of its
 Board of Directors.  Effective immediately, Mr. Edward Faber, a director since
 October 2000, will become Chairman of the Board of Directors.  Mr. Faber, who
 has over 30 years of experience building and managing high-technology growth
 companies, will be taking a more active role in the daily operations of the
 Company.  Mr. William Boone, a director since 1998 and who had previously
 retained the position of Chairman, will become Vice-Chairman of the Board of
 Directors.
     Mr. Kenneth Waters, who has been working with Gum Tech as a consultant
 since April 1998 and has been a director since November 2000, has resigned
 from the Board.  Mr. Waters will continue his business consulting agreement
 with the Company with his primary focus on Gum Tech's strategic options and
 long-term business plans.
     Mr. William Hemelt, Chief Financial Officer of Gum Tech since 1998, has
 accepted the additional position of Executive Vice President, Operations for
 the Company.  The added title reflects the corresponding responsibilities Mr.
 Hemelt has been assigned since the inception of Gel Tech LLC.
 
     Gum Tech International, Inc. is an innovative nutrient and drug delivery
 technology company engaged in the development, manufacture and marketing of
 delivery systems for bioactive compounds.  Gum Tech is the majority owner of
 Gel Tech LLC, which markets Zicam(TM) Cold Remedy, a patented, revolutionary
 homeopathic remedy, and Zicam(TM) Allergy Relief, a homeopathic remedy
 designed to provide relief to allergy sufferers.  In a study published in the
 October 2000 issue of the ENT - Ear, Nose & Throat Journal, Zicam(TM) Cold
 Remedy was shown to reduce the duration of the common cold by an average of
 75% when taken at the onset of symptoms.
 
     For additional information, please contact Lynn Romero, Manager of
 Investor Relations, 602-252-1617, ext. 320, lromero@gum-tech.com.  Gum Tech is
 located at 246 East Watkins Street, Phoenix, Arizona 85004.
 
     Gum Tech Forward-Looking Statement Disclaimer:
     This news release contains forward-looking statements within the
 meaning of the Private Securities Litigation Reform Act of 1995.  These
 forward-looking statements are based on the Company's expectations and are
 subject to a number of risks and uncertainties, many of which cannot be
 predicted or quantified and are beyond the Company's control.  Future events
 and actual results could differ materially from those set forth in,
 contemplated by, or underlying the forward-looking statements.  Factors that
 could cause actual results to differ materially from the Company's
 expectations are described in the Company's reports filed pursuant to the
 Securities Exchange Act of 1934.
 
 SOURCE  Gum Tech International Inc.